Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000082·CG Oncology, Inc.
Schedule 13G ownership disclosure
CG oncology Inc
Common Stock · CUSIP: 156944100
Event date: 2025-09-30
- Filing-level shares
- 6,577,281
- Percent of class
- 8.62%
- The Vanguard Group
Shares: 6,577,281 · Class: 8.62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000082
- Form type
- SCHEDULE 13G/A
- Filer
- CG Oncology, Inc.
- CIK
- CIK 1991792
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership